Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Pharmacogeomic implications of population diversity in Latin America: TPMT and NUDT15 polymorphisms and thiopurine dosing.

Suarez-Kurtz G, Araújo GS, de Sousa SJ.

Pharmacogenet Genomics. 2020 Jan;30(1):1-4. doi: 10.1097/FPC.0000000000000388.

PMID:
31651720
2.

4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.

Sipeky C, Llerena A, Manolopoulos VG, Pearson E, Mlakar V, Gozzo L, Simmaco M, Marchetti P, Re MD, Stankovic S, Meyer U, Cascorbi I, Ingelman-Sundberg M, Suarez-Kurtz G, Marc J, Katsila T, Paulmichl M, Nofziger C, Ansari M, Drago F, van Schaik RH.

Pharmacogenomics. 2019 Oct;20(15):1063-1069. doi: 10.2217/pgs-2019-0095.

PMID:
31588876
3.

NUDT15 Polymorphism in Native American Populations of Brazil.

Suarez-Kurtz G, Brisson GD, Hutz MH, Petzl-Erler ML, Salzano FM.

Clin Pharmacol Ther. 2019 Jun;105(6):1321-1322. doi: 10.1002/cpt.1379. Epub 2019 Mar 21. No abstract available.

PMID:
30897207
4.

Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.

Fernandes VC, Golubeva VA, Di Pietro G, Shields C, Amankwah K, Nepomuceno TC, de Gregoriis G, Abreu RBV, Harro C, Gomes TT, Silva RF, Suarez-Kurtz G, Couch FJ, Iversen ES, Monteiro ANA, Carvalho MA.

J Biol Chem. 2019 Apr 12;294(15):5980-5992. doi: 10.1074/jbc.RA118.005274. Epub 2019 Feb 14.

PMID:
30765603
5.

Pharmacogenomics research and clinical implementation in Brazil.

Rodrigues-Soares F, Suarez-Kurtz G.

Basic Clin Pharmacol Toxicol. 2019 May;124(5):538-549. doi: 10.1111/bcpt.13196. Epub 2019 Jan 24. Review.

PMID:
30589990
6.

Conference report: pharmacogenomics in special populations at WCP2018.

Suarez-Kurtz G, Aklillu E, Saito Y, Somogyi AA.

Br J Clin Pharmacol. 2019 Mar;85(3):467-475. doi: 10.1111/bcp.13828. Epub 2019 Jan 24. Review.

PMID:
30537134
7.

Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.

Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ, Borobia AM, Tong HY, Dávila-Fajardo C, Rodrigues Botton M, Bourgeois S, Deloukas P, Caldwell MD, Burmester JK, Berg RL, Cavallari LH, Drozda K, Huang M, Zhao LZ, Cen HJ, Gonzalez-Conejero R, Roldan V, Nakamura Y, Mushiroda T, Gong IY, Kim RB, Hirai K, Itoh K, Isaza C, Beltrán L, Jiménez-Varo E, Cañadas-Garre M, Giontella A, Kringen MK, Haug KBF, Gwak HS, Lee KE, Minuz P, Lee MTM, Lubitz SA, Scott S, Mazzaccara C, Sacchetti L, Genç E, Özer M, Pathare A, Krishnamoorthy R, Paldi A, Siguret V, Loriot MA, Kutala VK, Suarez-Kurtz G, Perini J, Denny JC, Ramirez AH, Mittal B, Rathore SS, Sagreiya H, Altman R, Shahin MHA, Khalifa SI, Limdi NA, Rivers C, Shendre A, Dillon C, Suriapranata IM, Zhou HH, Tan SL, Tatarunas V, Lesauskaite V, Zhang Y, Maitland-van der Zee AH, Verhoef TI, de Boer A, Taljaard M, Zambon CF, Pengo V, Zhang JE, Pirmohamed M, Johnson JA, Fava C.

Clin Pharmacol Ther. 2019 Jun;105(6):1477-1491. doi: 10.1002/cpt.1323. Epub 2019 Feb 17.

PMID:
30506689
8.

Pharmacogene Variation Consortium Gene Introduction: NUDT15.

Yang JJ, Whirl-Carrillo M, Scott SA, Turner AJ, Schwab M, Tanaka Y, Suarez-Kurtz G, Schaeffeler E, Klein TE, Miller NA, Gaedigk A.

Clin Pharmacol Ther. 2019 May;105(5):1091-1094. doi: 10.1002/cpt.1268. Epub 2018 Dec 4. No abstract available.

9.

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.

Relling MV, Schwab M, Whirl-Carrillo M, Suarez-Kurtz G, Pui CH, Stein CM, Moyer AM, Evans WE, Klein TE, Antillon-Klussmann FG, Caudle KE, Kato M, Yeoh AEJ, Schmiegelow K, Yang JJ.

Clin Pharmacol Ther. 2019 May;105(5):1095-1105. doi: 10.1002/cpt.1304. Epub 2019 Jan 20.

PMID:
30447069
10.

Pharmacogenetic testing in oncology: a Brazilian perspective.

Suarez-Kurtz G.

Clinics (Sao Paulo). 2018 Oct 11;73(suppl 1):e565s. doi: 10.6061/clinics/2018/e565s. Review.

11.

Uncovering association networks through an eQTL analysis involving human miRNAs and lincRNAs.

Branco PR, de Araújo GS, Barrera J, Suarez-Kurtz G, de Souza SJ.

Sci Rep. 2018 Oct 9;8(1):15050. doi: 10.1038/s41598-018-33420-z.

12.

Population Diversity in Pharmacogenetics: A Latin American Perspective.

Suarez-Kurtz G, Parra EJ.

Adv Pharmacol. 2018;83:133-154. doi: 10.1016/bs.apha.2018.02.001. Epub 2018 Mar 19. Review.

PMID:
29801573
13.

CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.

Brasil LW, Rodrigues-Soares F, Santoro AB, Almeida ACG, Kühn A, Ramasawmy R, Lacerda MVG, Monteiro WM, Suarez-Kurtz G.

Malar J. 2018 Feb 1;17(1):57. doi: 10.1186/s12936-017-2139-7.

14.

Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort.

Santoro AB, Botton MR, Struchiner CJ, Suarez-Kurtz G.

Br J Clin Pharmacol. 2018 May;84(5):987-996. doi: 10.1111/bcp.13522. Epub 2018 Feb 26.

15.

The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.

Nepomuceno TC, De Gregoriis G, de Oliveira FMB, Suarez-Kurtz G, Monteiro AN, Carvalho MA.

Int J Mol Sci. 2017 Aug 31;18(9). pii: E1886. doi: 10.3390/ijms18091886. Review.

16.

DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.

De Gregoriis G, Ramos JA, Fernandes PV, Vignal GM, Brianese RC, Carraro DM, Monteiro AN, Struchiner CJ, Suarez-Kurtz G, Vianna-Jorge R, de Carvalho MA.

Cancer Biol Ther. 2017 Jun 3;18(6):439-449. doi: 10.1080/15384047.2017.1323590. Epub 2017 May 5.

17.

BRCA1 recruitment to damaged DNA sites is dependent on CDK9.

Nepomuceno TC, Fernandes VC, Gomes TT, Carvalho RS, Suarez-Kurtz G, Monteiro AN, Carvalho MA.

Cell Cycle. 2017 Apr 3;16(7):665-672. doi: 10.1080/15384101.2017.1295177. Epub 2017 Feb 22.

18.

Differential effects of predictors of warfarin dose according to race/color categories in the admixed Brazilian population.

Suarez-Kurtz G, Struchiner CJ.

Pharmacogenet Genomics. 2017 May;27(5):210-211. doi: 10.1097/FPC.0000000000000273. No abstract available.

PMID:
28263279
19.

Conference Report: First Pharmacogenetics and Precision Medicine Conference in Africa (April 7-9, 2016, Cape Town, South Africa).

Dandara C, Suarez-Kurtz G, Aklillu E.

OMICS. 2016 Sep;20(9):496-7. doi: 10.1089/omi.2016.0128. No abstract available.

PMID:
27631188
20.

L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer: Effect of a novel UGT1 marker, rs11563250A > G.

Santoro AB, Struchiner CJ, Suarez-Kurtz G.

Br J Clin Pharmacol. 2016 Nov;82(5):1402-1403. doi: 10.1111/bcp.13064. Epub 2016 Aug 16. No abstract available.

Supplemental Content

Loading ...
Support Center